UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  June 6, 2008

 

Angeion Corporation

(Exact name of registrant as specified in its charter)

 

Minnesota

(State or other jurisdiction of incorporation)

 

001-13543

 

41-1579150

(Commission File Number)

 

(IRS Employer Identification No.)

 

350 Oak Grove Parkway

 

 

Saint Paul, Minnesota

 

55127-8599

(Address of principal executive offices)

 

(Zip Code)

 

651.484.4874

(Registrant’s telephone number, including area code)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Section 5                                             Corporate Governance and Management

Item 5.02                                             Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Departures of Directors or Certain Officers; Compensatory Arrangements of Certain Officers

 

On June 6, 2008, Arnold A. Angeloni retired as Chair and a director of Angeion Corporation, and the Board of Directors of Angeion elected K. James Ehlen, M.D. as new Chair of the Angeion Board of Directors.  A copy of the Angeion press release announcing Mr. Angeloni’s resignation and the election of Dr. Ehlen as Chair is furnished as Exhibit 99.1.

 

Section 9 – Financial Statements and Exhibits

Item 9.01   Financial Statements and Exhibits

 

(d)                                 Exhibits

 

The following is furnished as an Exhibit to this Report:

 

Exhibit No.

 

Description of Exhibit

 

 

 

99.1

 

Press release dated June 9, 2008

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ANGEION CORPORATION

 

 

 

 

 

 

Dated: June 9, 2008

By:

/s/ Rodney A. Young

 

 

Rodney A. Young

 

 

President and Chief Executive Officer

 

2